// App-Quantinova.ai

P648 : The impact of infliximab therapeutic drug monitoring on decisions made in a virtual biologics clinic for IBD

Researchers

Presenter

  • C. Selinger

Principal Investigators

  • M. Lenti

  • T. Clark

  • H. Rafferty

  • A. O'Connor

  • T. Ahmad

  • J. Hamlin

Medical Centers

  • St. James' University Hospital, Gastroenterology, Leeds, United Kingdom

  • Royal Devon & Exeter NHS Foundation Trust, Blood Sciences, Exeter, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved